$CCXI ChemoCentryx, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ChemoCentryx, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ChemoCentryx, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in ChemoCentryx, Inc. for free.

CIK Number: 0001340652
IRS Number: 943254365
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CCXI
Company Address: 850 MAUDE AVENUE MOUNTAIN VIEW 94043

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Market Capitalization: $309.30M
Prev close: $6.67
Average Daily Volume: 248,834
Days Low: $6.45
Year Low: $1.92
Year High: $9.10

ChemoCentryx, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Cappel Markus J.Chief Bus. Officer & Treasurer118,878792,916shares bought: 910,142 / shares sold: -875,992 BUYMar 05 20201 month ago
Jain RitaDirector12,97586,543shares bought: 12,975 / shares sold: 0 STRONG BUYMar 31 20209 days ago
KANAYA SUSAN MEVP, CFO and Sec.118,380789,595shares bought: 1,114,986 / shares sold: -883,813 BUYMar 05 20201 month ago
Kwan Pui SanPrincipal Acctg Officer4933,288shares bought: 213,091 / shares sold: -232,032 SELLMar 31 20209 days ago
Parker Geoffrey M.Director76,401509,595shares bought: 143,490 / shares sold: -42,815 STRONG BUYMar 25 202014 days ago
Schall Thomas J.President and CEO2,309,40115,403,705shares bought: 1,369,054 / shares sold: -1,353,676 BUYMar 05 20201 month ago
Tyree James LDirector20,060133,800shares bought: 53,490 / shares sold: -35,544 BUYJan 15 20203 months ago

View all ChemoCentryx, Inc. insiders.

ChemoCentryx, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 31 2020CCXIChemoCentryx, Inc.Kwan Pui SanPrincipal Acctg Off ...Option ExerciseA46.5216,510768,04516,510
Mar 31 2020CCXIChemoCentryx, Inc.Jain RitaDirectorOption ExerciseM0.005,251010,502
Mar 31 2020CCXIChemoCentryx, Inc.Jain RitaDirectorBuyM0.005,251012,9757.7 K to 13 K (+67.98 %)
Mar 25 2020CCXIChemoCentryx, Inc.Parker Geoffrey M.DirectorSellS38.2186032,86349,60050.5 K to 49.6 K (-1.70 %)
Mar 25 2020CCXIChemoCentryx, Inc.Parker Geoffrey M.DirectorSellS37.4013,959522,00850,46064.4 K to 50.5 K (-21.67 %)
Mar 25 2020CCXIChemoCentryx, Inc.Parker Geoffrey M.DirectorSellS36.729,181337,10064,41973.6 K to 64.4 K (-12.47 %)
Mar 25 2020CCXIChemoCentryx, Inc.Parker Geoffrey M.DirectorSellS35.322,80198,93273,60076.4 K to 73.6 K (-3.67 %)
Mar 25 2020CCXIChemoCentryx, Inc.Parker Geoffrey M.DirectorSellS34.433,199110,14776,40179.6 K to 76.4 K (-4.02 %)
Mar 05 2020CCXIChemoCentryx, Inc.Schall Thomas J.President and CEOOption ExerciseA46.5971,5003,331,18571,500
Mar 05 2020CCXIChemoCentryx, Inc.Schall Thomas J.President and CEOOption ExerciseA0.00103,7000103,700
Mar 05 2020CCXIChemoCentryx, Inc.Schall Thomas J.President and CEOOption ExerciseM14.3140,844584,478246,038
Mar 05 2020CCXIChemoCentryx, Inc.Schall Thomas J.President and CEOSellS50.3540,8442,056,6912,268,5572.3 M to 2.3 M (-1.77 %)
Mar 05 2020CCXIChemoCentryx, Inc.Schall Thomas J.President and CEOBuyM14.3140,844584,4782,309,4012.3 M to 2.3 M (+1.80 %)
Mar 05 2020CCXIChemoCentryx, Inc.KANAYA SUSAN MEVP, CFO and Sec.Option ExerciseA46.5921,400997,02621,400
Mar 05 2020CCXIChemoCentryx, Inc.KANAYA SUSAN MEVP, CFO and Sec.Option ExerciseA0.0031,000031,000

View all ChemoCentryx, Inc. insider transactions.